Is Teva Pharmaceutical Industries (TEVA) A Bargain On Its TEV 408 Phase 2b Move?Simplywall·2 days ago, 02:34 PMTEVA-0.84%
Teva Pharmaceutical Industries (NYSE:TEVA) Sets New 1-Year High After Analyst UpgradeMarket Beat·Aug 13 at 09:40 AMTEVA-0.84%
Teva Pharmaceutical Industries (NYSE:TEVA) Price Target Raised to $42.00Market Beat·Aug 12 at 07:48 AMTEVA-0.84%
Pacer Advisors Inc. Sells 484,736 Shares of Teva Pharmaceutical Industries Ltd. $TEVAMarket Beat·Aug 12 at 03:56 AMTEVA-0.84%
Moody’s Ratings Upgrades Teva to Investment Grade, Reflecting the Ongoing Execution of Pivot to Growth StrategyUnusual Whales·Aug 11 at 07:03 AMTEVA-0.84%
Assenagon Asset Management S.A. Grows Position in Teva Pharmaceutical Industries Ltd. $TEVAMarket Beat·Aug 8 at 02:28 AMTEVA-0.84%
Teva Pharmaceutical Industries (TEVA) Lifts Outlook On Earnings As Valuation Debate Stays OpenSimplywall·Aug 7 at 10:48 AMTEVA-0.84%
Arrowstreet Capital Limited Partnership Reduces Stock Holdings in Teva Pharmaceutical Industries Ltd. $TEVAMarket Beat·Aug 7 at 02:12 AMTEVA-0.84%
Teva Pharmaceutical Industries Ltd. $TEVA Shares Purchased by Royal Bank of CanadaMarket Beat·Aug 5 at 04:04 AMTEVA-0.84%
Drugmakers Climb On Q2 Reports, Even As One Misses Profit ViewsUnusual Whales·Jul 29 at 02:04 PMTEVA-0.84%
U.S. stock market midday update: Teva Pharmaceutical Industries rises 10.19%, raises expectations and acquires Emalex to boost confidencePrice Alert·Jul 29 at 01:13 PMTEVA-0.84%
TEVA: Innovative product growth and biosimilars drive raised outlook and strong cash flow in Q2 2026Quartr·Jul 29 at 09:59 AMTEVA-0.84%
